NasdaqGS - Delayed Quote USD
Allogene Therapeutics, Inc. (ALLO)
1.7000
+0.0100
+(0.59%)
At close: May 2 at 4:00:01 PM EDT
1.7000
0.00
(0.00%)
Pre-Market: 7:00:00 AM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 1,482,872 | 7 |
| Sales | 210,972 | 12 |
| Net Shares Purchased (Sold) | 1,271,900 | 19 |
| Total Insider Shares Held | 37.4M | -- |
| % Net Shares Purchased (Sold) | 3.50% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| YOSHIYAMA ANNIE Officer | Sale at price 1.41 per share. | Direct | 13,537 | Apr 21, 2025 |
| CHANG DAVID D M.D., PH.D. Chief Executive Officer | Sale at price 1.96 per share. | Direct | 91,469 | Mar 14, 2025 |
| MESSEMER DEBORAH M Director | Sale at price 2.43 per share. | Direct | 32,351 | Feb 18, 2025 |
| DOUGLAS EARL MARTIN General Counsel | Sale at price 1.71 per share. | Direct | 10,951 | Feb 3, 2025 |
| CHANG DAVID D M.D., PH.D. Chief Executive Officer | Sale at price 1.68 per share. | Direct | 77,285 | Feb 3, 2025 |
| MOORE TIMOTHY L. Chief Technology Officer | Sale at price 1.71 per share. | Direct | 25,216 | Feb 3, 2025 |
| PARKER GEOFFREY M Chief Financial Officer | Sale at price 1.73 per share. | Direct | 7,545 | Feb 3, 2025 |
| ROBERTS ZACHARY Officer | Sale at price 1.70 per share. | Direct | 32,014 | Feb 3, 2025 |
| BELLDEGRUN ARIE S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 24, 2025 |
| DOUGLAS EARL MARTIN General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 24, 2025 |
| CHANG DAVID D M.D., PH.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 24, 2025 |
| PARKER GEOFFREY M Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 24, 2025 |
| YOSHIYAMA ANNIE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 24, 2025 |
| ROBERTS ZACHARY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 24, 2025 |
| ROBERTS ZACHARY Officer | Sale at price 1.78 per share. | Direct | 48,414 | Jan 21, 2025 |
| MESSEMER DEBORAH M Director | Sale at price 2.18 per share. | Direct | 19,916 | Dec 9, 2024 |
| HUMER FRANZ B Director | Sale at price 2.16 per share. | Direct | 19,917 | Dec 5, 2024 |
| MESSEMER DEBORAH M Director | Sale at price 2.28 per share. | Direct | 42,488 | Jun 18, 2024 |
| SATO VICKI LEE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 5, 2024 |
| HUMER FRANZ B Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 5, 2024 |
| MESSEMER DEBORAH M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 5, 2024 |
| HUMER FRANZ B Director | Sale at price 2.34 per share. | Direct | 26,181 | May 30, 2024 |
| BELLDEGRUN ARIE S Director | Stock Award(Grant) at price 2.90 per share. | Indirect | 1,000,001 | May 16, 2024 |
| CHANG DAVID D M.D., PH.D. Chief Executive Officer | Stock Award(Grant) at price 2.90 per share. | Direct | 1,000,001 | May 16, 2024 |
| PARKER GEOFFREY M Chief Financial Officer | Stock Award(Grant) at price 2.90 per share. | Direct | 1,000,001 | May 16, 2024 |
| BELLDEGRUN ARIE S Director | Purchase at price 2.90 per share. | Indirect | 4,999,997 | May 16, 2024 |
| PARKER GEOFFREY M Chief Financial Officer | Purchase at price 3.60 per share. | Direct | 683 | Jan 30, 2024 |
| BELLDEGRUN ARIE S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 25, 2024 |
| DOUGLAS EARL MARTIN General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 25, 2024 |
| CHANG DAVID D M.D., PH.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 25, 2024 |
| MOORE TIMOTHY L. Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 25, 2024 |
| PARKER GEOFFREY M Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 25, 2024 |
| ROBERTS ZACHARY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 25, 2024 |
| MESSEMER DEBORAH M Director | Sale at price 2.70 per share. | Direct | 50,317 | Dec 18, 2023 |
| PARKER GEOFFREY M Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Oct 16, 2023 |
| DOUGLAS EARL MARTIN General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 14, 2023 |
| CHEN YINLIN JACK Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 10, 2023 |
| MAYO STEPHEN L. Director | Sale at price 4.29 per share. | Direct | 42,855 | Aug 7, 2023 |
| SATO VICKI LEE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2023 |
| HUMER FRANZ B Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2023 |
| WITTE OWEN N Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2023 |
| MESSEMER DEBORAH M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 13, 2023 |
Related Tickers
FATE Fate Therapeutics, Inc.
1.3100
+5.65%
AUTL Autolus Therapeutics plc
1.3500
0.00%
CRBU Caribou Biosciences, Inc.
0.8800
+9.75%
ALXO ALX Oncology Holdings Inc.
0.5329
+3.34%
ATRA Atara Biotherapeutics, Inc.
7.82
+3.44%
NKTX Nkarta, Inc.
2.0900
+1.95%
SANA Sana Biotechnology, Inc.
1.8900
-0.53%
MRSN Mersana Therapeutics, Inc.
0.3977
-0.57%
PRME Prime Medicine, Inc.
1.6800
-3.45%
CLLS Cellectis S.A.
1.5910
-1.18%